Tag Archives | cardiovascular disease

J.P.Morgan Healthcare Conference: Picks and Trades Update

JPMorgan Healthcare Conference Picks and Trades: AMRN,GNMK,TDOC. Many sector Indexes are up over 10% YTD: Small caps: IJR,IWM,XBI; NASDAQ-100 QQQ Trending Up: Many mid-cap biopharmas on our watch list are still way below 2018 highs but many are recovering above the mid-point : ARRY, ARNA, GWPH, ICPT, INCY ,IONS, SRPT, SGEN, NVCR. We attended the […]

Continue Reading 0

Emerging Growth Stocks: Long Ideas in Life Science for 2019…Updates-Risk On…FED on Hold and “Patient”

Update ….Jan 30 2:45p  EST …FED to be Patient and Policy Stance is Appropriate FED to “wait and see” before raising rates-stocks soar. FED-“US Economy in a good place” NASDAQ up 2%, DOW up 1.73%, S&P up 1.53% XLV up 1.27%, IBB flat, XBI up 1.72%. Large cap biopharmas trail broad rally: AMGN,BIIB in the […]

Continue Reading 0

AACC Notes: Biomarkers for Cardiovascular Risk-hsCRP

Last week’s Plenary Session from the AACC featured Paul Ridker.MD,MPH from Brigham and Women’s Hospital ,Boston,MA speaking about Inflammation,hsCRP and Cardiovascular Prevention. The session reviewed data from the JUPITER trial for the use of statins in primary cardiovascular prevention. Dr. Ridker believes that the biomarker hsCRP (high sensitivity C-reactive protein) in combination with LDL are […]

Continue Reading 0